Globus Medical Total Liabilities 2010-2023 | GMED
Globus Medical total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Globus Medical total liabilities for the quarter ending March 31, 2023 were $0.235B, a 10.07% increase year-over-year.
- Globus Medical total liabilities for 2022 were $0.23B, a 6.43% increase from 2021.
- Globus Medical total liabilities for 2021 were $0.216B, a 24.65% increase from 2020.
- Globus Medical total liabilities for 2020 were $0.173B, a 33.61% increase from 2019.
Globus Medical Annual Total Liabilities (Millions of US $) |
2022 |
$230 |
2021 |
$216 |
2020 |
$173 |
2019 |
$130 |
2018 |
$115 |
2017 |
$111 |
2016 |
$96 |
2015 |
$119 |
2014 |
$118 |
2013 |
$94 |
2012 |
$61 |
2011 |
$47 |
2010 |
$38 |
2009 |
$0 |
Globus Medical Quarterly Total Liabilities (Millions of US $) |
2023-03-31 |
$235 |
2022-12-31 |
$230 |
2022-09-30 |
$212 |
2022-06-30 |
$216 |
2022-03-31 |
$213 |
2021-12-31 |
$216 |
2021-09-30 |
$192 |
2021-06-30 |
$191 |
2021-03-31 |
$175 |
2020-12-31 |
$173 |
2020-09-30 |
$125 |
2020-06-30 |
$129 |
2020-03-31 |
$116 |
2019-12-31 |
$130 |
2019-09-30 |
$113 |
2019-06-30 |
$103 |
2019-03-31 |
$99 |
2018-12-31 |
$115 |
2018-09-30 |
$97 |
2018-06-30 |
$97 |
2018-03-31 |
$101 |
2017-12-31 |
$111 |
2017-09-30 |
$102 |
2017-06-30 |
$90 |
2017-03-31 |
$92 |
2016-12-31 |
$96 |
2016-09-30 |
$92 |
2016-06-30 |
$90 |
2016-03-31 |
$91 |
2015-12-31 |
$119 |
2015-09-30 |
$127 |
2015-06-30 |
$122 |
2015-03-31 |
$130 |
2014-12-31 |
$118 |
2014-09-30 |
$93 |
2014-06-30 |
$90 |
2014-03-31 |
$97 |
2013-12-31 |
$94 |
2013-09-30 |
$76 |
2013-06-30 |
$76 |
2013-03-31 |
$65 |
2012-12-31 |
$61 |
2012-09-30 |
$52 |
2012-06-30 |
$46 |
2012-03-31 |
$53 |
2011-12-31 |
$47 |
2011-09-30 |
$0 |
2011-06-30 |
$0 |
2011-03-31 |
$0 |
2010-12-31 |
$38 |
2009-12-31 |
$0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Instruments Manufacturing |
$5.519B |
$0.759B |
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
|